Enhancing Molecular Network‐Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Hao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Neoplasms, Machine Learning, Gene Regulatory Networks, Computational Biology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer is a complex disease driven by mutations in the genes that play critical roles in cellular processes. The identification of cancer driver genes is crucial for understanding tumorigenesis, developing targeted therapies and identifying rational drug targets. Experimental identification and validation of cancer driver genes are time‐consuming and costly. Studies have demonstrated that interactions among genes are associated with similar phenotypes. Therefore, identifying cancer driver genes using molecular network‐based approaches is necessary. Molecular network‐based random walk‐based approaches, which integrate mutation data with protein–protein interaction networks, have been widely employed in predicting cancer driver genes and demonstrated robust predictive potential. However, recent advancements in deep learning, particularly graph‐based models, have provided novel opportunities for enhancing the prediction of cancer driver genes. This review aimed to comprehensively explore how machine learning methodologies, particularly network propagation, graph neural networks, autoencoders, graph embeddings, and attention mechanisms, improve the scalability and interpretability of molecular network‐based cancer gene prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Wenzhou Key Laboratory of Biophysics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China.
- Wenzhou Longwan High School, Wenzhou, Zhejiang, China.
ORCID-Profile: Jie Lyu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, H., Lin, C., Chen, Y., Shen, X., Wang, R., Chen, Y., & Lyu, J. (2025). Enhancing Molecular Network‐Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70351
Vancouver
Zhang H, Lin C, Chen Y, Shen X, Wang R, Chen Y, et al. Enhancing Molecular Network‐Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70351
BibTeX
@article{Zhang2025,
author = {Zhang, Hao and Lin, Chaohuan and Chen, Ying'ao and Shen, Xianrui and Wang, Ruizhe and Chen, Yiqi and Lyu, Jie},
title = {Enhancing Molecular Network‐Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70351}
}
EUVIMED